Heiko Schuster

Title: Heiko Schuster: Innovator in Antibody Constructs

Introduction

Heiko Schuster is a notable inventor based in Tubingen, Germany. He is recognized for his contributions to the field of biotechnology, particularly in the development of antibody constructs. His innovative work has led to advancements in medical applications, showcasing the potential of his inventions in therapeutic settings.

Latest Patents

Heiko Schuster holds a patent for MAGEB2 binding constructs. The present invention relates to antibody constructs comprising a domain that binds to a MAGEB2 peptide complexed with an HLA and optionally, another domain that binds to CD3. Moreover, the invention provides polynucleotides encoding the antibody constructs, vectors comprising said polynucleotides, and host cells transformed or transfected with said polynucleotides or vectors. Furthermore, the invention outlines processes for producing the antibody constructs, medical uses of said antibody constructs, and kits comprising said antibody constructs. He has 1 patent to his name.

Career Highlights

Throughout his career, Heiko Schuster has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has contributed significantly to his expertise in the field.

Collaborations

Heiko Schuster has collaborated with several professionals in his field, including Ian Nevin Foltz and Weihsu Claire Chen. These collaborations have likely enriched his research and development efforts, fostering innovation in antibody constructs.

Conclusion

Heiko Schuster's work in developing MAGEB2 binding constructs exemplifies the intersection of innovation and biotechnology. His contributions continue to influence the medical field, paving the way for future advancements in therapeutic applications.